Secretion of GM-CSF by inflammatory cells in the lung of patients with sarcoidosis

Respirology

Volumn 3, Issue 4, 1998, Pages 247-251

  Itoh, Akihide ^a   Yamaguchi, Etsuro ^a   Furuya, Ken ^a   Kawakami, Yoshikazu ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Bronchoalveolar lavage; GM CSF; Pulmonary sarcoidosis

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; INFLAMMATORY CELL; LUNG ALVEOLUS MACROPHAGE; LUNG LAVAGE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SARCOIDOSIS;

EID: 0032461649     PISSN: 13237799     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1843.1998.tb00130.x     Document Type: Article

References (7)

1. NIH Conference. Pulmonary sarcoidosis: a disease characterized and perpetuated by activated lung T-lymphocytes. Ann. Intern. Med. 1981; 94: 73-94.
2. du Bois RM. Sarcoidosis. In: Walters EH, du Bois RM (eds) Immunology and Management of Interstitial Lung Diseases. Chapman & Hall, London, 1995; 97-122.
3. Itoh A, Yamaguchi E, Kuzumaki N et al. Expression of granulocyte-macrophage colony-stimulating factor mRNA by inflammatory cells in the sarcoid lung. Am. J. Resp. Cell. Mol. Biol. 1990; 3: 245-9.
4. Itoh A, Yamaguchi E, Furuya K et al. Correlation of GM-CSF mRNA in bronchoalveolar fluid with indices of clinical activity in sarcoidosis. Thorax 1993; 48: 1230-4.
5. Baldwin GC. The biology of granulocyte-macrophage colony-stimulating factor: effects on hematopoietic and nonhematopoietic cells. Dev. Biol. 1992; 151: 352-7.
6. Hunninghake GW, Crystal RG. Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity. N. Engl. J. Med. 1981; 305: 429-34.
7. Yamaguchi E, Okazaki N, Tsuneta Y, Abe S, Terai T, Kawakami Y. Interleukins in pulmonary sarcoidosis. Dissociative correlations of lung interleukins 1 and 2 with the intensity of alveolitis. Am. Rev. Resp. Dis. 1988; 138: 645-51.